On February 17, the China-Swiss Companies Investment Cooperation Exchange was held in Beijing, marking the first foreign-related investment exchange event in the city after Spring Festival.

1. Promotion of regional advantages on-site
The Beijing Municipal Science and Technology Commission (BMSTC), the National Medical Products Administration, and authorities from Chaoyang, Haidian, and Mentougou districts introduced and promoted Beijing's industrial policies and specialized industrial parks. Local enterprises actively engaged with Swiss companies for cooperation and capital connections, providing diverse investment options in Beijing.

2. On-site enterprise agreements
Beijing Danao Biotechnology Co., Ltd., Swiss Orexa, and UK-based Kadence Bio have signed strategic cooperation agreements with Cidesis Group. Danao Biotechnology will invest in Switzerland with Cidesis Group to promote assisted reproductive technologies and products. Orexa and Kadence Bio plan to establish operations in Beijing to further expand into the Chinese market.

3. On-site inspections and visits
A "research + production + implementation" inspection route was designed to provide a comprehensive industrial chain guide for enterprises developing in Beijing. The Swiss business delegation visited key industrial parks such as Changping Life Science Park and Daxing Medical Device Park. They also toured Beijing Feidiao International Innovation Platform and Gaobo Hospital, showcasing Beijing's strengths in clinical resources, market potential, and policy support, further enhancing Swiss enterprises' confidence in investing in Beijing.

(Source: Beijing Investment Promotion Bureau)